Cargando…

Decentralised clinical trials in multiple sclerosis research

Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garjani, Afagh, Liu, Brandon Jun-Yu, Allen, Christopher Martin, Gunzler, Douglas David, Gerry, Stephen William, Planchon, Sarah Marie, das Nair, Roshan, Chataway, Jeremy, Tallantyre, Emma C, Ontaneda, Daniel, Evangelou, Nikos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Topical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972228/ https://www.ncbi.nlm.nih.gov/pubmed/35735014 http://dx.doi.org/10.1177/13524585221100401

Ejemplares similares

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
por: Garjani, Afagh, et al.
Publicado: (2021)

Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
por: Garjani, Afagh, et al.
Publicado: (2021)

Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review
por: Alexander, Sarah, et al.
Publicado: (2020)

Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register
por: Evangelou, Nikos, et al.
Publicado: (2021)

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years
por: Hawton, Annie, et al.
Publicado: (2020)

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
por: Dumitrescu, Laura, et al.
Publicado: (2023)

Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study
por: das Nair, Roshan, et al.
Publicado: (2021)

Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
por: Garjani, Afagh, et al.
Publicado: (2022)

Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success
por: Marck, Claudia H, et al.
Publicado: (2019)

Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial
por: Topcu, Gogem, et al.
Publicado: (2022)

Self-help Acceptance and Commitment Therapy for Carers of People with Multiple Sclerosis: A Feasibility Randomised Controlled Trial
por: Potter, Kristy-Jane, et al.
Publicado: (2020)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2017)

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting
por: Baldassari, Laura E, et al.
Publicado: (2019)

Developing a patient care pathway for emotional support around the point of multiple sclerosis diagnosis: A stakeholder engagement study
por: Tindall, Tierney, et al.
Publicado: (2023)

How to run a multiple sclerosis relapse clinic
por: Tallantyre, Emma C, et al.
Publicado: (2016)

Diagnosis and Management of Progressive Multiple Sclerosis
por: Macaron, Gabrielle, et al.
Publicado: (2019)

Thalamic Injury and Cognition in Multiple Sclerosis
por: Amin, Moein, et al.
Publicado: (2021)

Pregnancy, sex and hormonal factors in multiple sclerosis
por: Miller, David H, et al.
Publicado: (2014)

Neurofilaments in progressive multiple sclerosis: a systematic review
por: Williams, Thomas, et al.
Publicado: (2020)

Neuromodulation for functional bladder disorders in patients with multiple sclerosis
por: Rahnama’i, Mohammad Sajjad
Publicado: (2019)

In vivo imaging of chronic active lesions in multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2020)

Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
por: Titball, Richard W, et al.
Publicado: (2023)

Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies
por: Topcu, Gogem, et al.
Publicado: (2022)

Management of acute exacerbations in multiple sclerosis
por: Ontaneda, Daniel, et al.
Publicado: (2009)

The challenges and opportunities of multiple sclerosis care in Latin America
por: Ontaneda, Daniel, et al.
Publicado: (2017)

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
por: Hartung, Hans-Peter, et al.
Publicado: (2015)

What’s in a name? That which we call Multiple Sclerosis Fatigue
por: Hubbard, Amy Lynn, et al.
Publicado: (2020)

Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
por: Olbert, Elisabeth, et al.
Publicado: (2022)

Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study
por: Papathanasiou, Athanasios, et al.
Publicado: (2023)

Dorsolateral prefrontal circuit effective connectivity mediates the relationship between white matter structure and PASAT‐3 performance in multiple sclerosis
por: Meng, Dewen, et al.
Publicado: (2020)

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
por: Bennett, JL, et al.
Publicado: (2015)

The Decentralisation of Great Cities
Publicado: (1898)

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

Decentralised clinical trials: ethical opportunities and challenges
por: Vayena, Effy, et al.
Publicado: (2023)

Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis
por: Feng, Jenny, et al.
Publicado: (2019)

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
por: Moser, Tobias, et al.
Publicado: (2022)

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review
por: Karim, Mohammad Ehsanul, et al.
Publicado: (2020)

The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids
por: Rakusa, Martin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ouf0i4jdrflrr1bpif06e4qd89